McKesson shares rise 4.4% after extending CVS Health deal through June 2032
AI Summary- McKesson extended its pharmaceutical distribution agreement in principle with CVS Health through June 2032.
- 4.4% was McKesson’s share-price gain Thursday after the agreement announcement.
- McKesson will provide further updates on November 4, 2026, during its fiscal 2027 second-quarter earnings call.